| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10756b2494a25415fecb3500b8709c51 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a86afd9346d6338cee45fb905453614d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724d2a14349ba7ecba33cd55fd57ec64 |
| publicationDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010129847-A1 |
| titleOfInvention |
Method for the detection of amyloid-b oligomers in body fluids |
| abstract |
The present invention relates to a method for the detection of marker of the Alzheimer's disease, namely the amyloid-β oligomers in human CSF, using a combination of steps including demasking the epitopes responsible for antibody binding on the Aβ peptide oligomers as well as detecting fluorescently marked antibodies binding to said epitopes, preferably by using the FRET technology. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11536731-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018136910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9588129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015311836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10139419-B2 |
| priorityDate |
2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |